Literature DB >> 28785366

Multiple Primary Recurrent Basaliomas (mPR-BCCs) of the Scalp with Cranial Bone Invasion.

Georgi Tchernev1, James W Patterson2, Torello Lotti3, Serena Gianfaldoni4, Jacopo Lotti5, Katlein França6, Atanas Batashki7, Uwe Wollina8.   

Abstract

We present a 68-year-old patient with multiple primary infiltrative BCCs in the scalp area, initially treated 14 years ago with superficial contact X-ray therapy, end dose 60 greys, followed by electrocautery (x2) several years later. He presented in the dermatologic policlinic for diagnosis and therapy of two additional, newly-formed pigmented lesions, and because of an uncomfortable, itchy, burning sensation in the area where lesions had been treated years before. Screening cranial computer-tomography (CT) examination revealed two deformities in the form of tumor-mediated osteolysis, affecting the diploe of the tabula externa on the left parietal and parasagittal areas. Complete excision with removal of periosteum and partial removal of the tabula externa was planned with neurosurgeons at a later stage. BCC is one of the most common malignant skin tumours of the head and neck region (about 90% of cases) and is characterised by a significant potential for local infiltration and destructive growth. Recurrent, invasive BCC of the scalp and calvarium is a difficult problem for which universally accepted treatment protocols had not been established. The primary treatment of aggressive BCCs is surgical, with a thorough examination of excision margins to ensure complete resection. Procedural-based options include standard excision, curettage, curettage with electrodessication, and Mohs micrographic surgery (MMS), with MMS being the gold standard for the definitive treatment of BCC. Improper removal or electrocautery (as in our case) of the several aggressive forms of BCC seems to be a particular problem, and not only for dermatologic surgeons. The risk of subsequent invasion and destruction of the cranium, underlying dura, and cranial nerves by basal cell carcinoma (BCC) is extremely low, with an estimated incidence of 0.03%, but is a potential complication over time. Computed tomography is the modality of choice for detecting tumour invasion into bone, which commonly appears as irregular demineralization or osteolysis.

Entities:  

Keywords:  adequate therapy; basal cell carcinoma; cranial bone invasion; selctrosurgery; surgery

Year:  2017        PMID: 28785366      PMCID: PMC5535691          DOI: 10.3889/oamjms.2017.145

Source DB:  PubMed          Journal:  Open Access Maced J Med Sci        ISSN: 1857-9655


We present a 68-year-old patient with multiple primary infiltrative BCCs in the scalp area, initially treated 14 years ago with superficial contact X-ray therapy, end dose 60 greys, followed by electrocautery (x2) several years later (Fig. 1a). He presented in the dermatologic policlinic for diagnosis and therapy of two additional, newly-formed pigmented lesions, and because of an uncomfortable, itchy, burning sensation in the area where lesions had been treated years before (Fig. 1a-d).
Figure 1

Lesions of the scalp in our patient. 1a) Ulcerated lesions - see horizontally oriented arrows. Horizontally oriented arrows also show histopathologically verified infiltrative BCCs that had been treated in the past. Vertically oriented arrows show newly pigmented BCCs; 1b-d) Horizontally oriented arrows show the older BCCs, treated in the past via radiation and elctrodesiccation

Lesions of the scalp in our patient. 1a) Ulcerated lesions - see horizontally oriented arrows. Horizontally oriented arrows also show histopathologically verified infiltrative BCCs that had been treated in the past. Vertically oriented arrows show newly pigmented BCCs; 1b-d) Horizontally oriented arrows show the older BCCs, treated in the past via radiation and elctrodesiccation Screening cranial computer-tomography (CT) examination revealed two deformities in the form of tumor-mediated osteolysis, affecting the diploe of the tabula externa on the left parietal and parasagittal areas. Complete excision with removal of periosteum and partial removal of the tabula externa was planned with neurosurgeons at a later stage. BCC is one of the most common malignant skin tumours of the head and neck region (about 90% of cases) and is characterised by a significant potential for local infiltration and destructive growth [1]. Recurrent, invasive BCC of the scalp and calvarium is a difficult problem for which universally accepted treatment protocols had not been established [2]. The primary treatment of aggressive BCCs is surgical, with a thorough examination of excision margins to ensure complete resection [3]. Procedural-based options include standard excision, curettage, curettage with electrodessication, and Mohs micrographic surgery (MMS), with MMS being the gold standard for the definitive treatment of BCC [4]. Improper removal or electrocautery (as in our case) of the several aggressive forms of BCC seems to be a particular problem, and not only for dermatologic surgeons. The risk of subsequent invasion and destruction of the cranium, underlying dura, and cranial nerves by basal cell carcinoma (BCC) is extremely low, with an estimated incidence of 0.03%, but is a potential complication over time [5]. Computed tomography is the modality of choice for detecting tumour invasion into bone, which commonly appears as irregular demineralization or osteolysis [5].
  5 in total

1.  Recalcitrant Invasive Skin Cancer of the Scalp: Combined Extirpation and Microsurgical Reconstruction Without Cranioplasty.

Authors:  Gerald J Cho; Frederick Wang; Steven M Garcia; Jennifer Viner; William Y Hoffman; Michael W McDermott; Jason H Pomerantz
Journal:  J Craniofac Surg       Date:  2017-03       Impact factor: 1.046

Review 2.  Recurrent basal cell carcinoma with intracranial invasion: a case report and literature review.

Authors:  Joseph Blackmon; Mac Machan; Anand Rajpara; Robert Beatty
Journal:  Dermatol Online J       Date:  2014-07-15

3.  Surgical treatment and dilemmas in the treatment of basal cell carcinomas with intracranial propagation.

Authors:  Lukas G Rasulić; Milan D Jovanović
Journal:  Vojnosanit Pregl       Date:  2014-11       Impact factor: 0.168

4.  Giant basal cell carcinoma of the forehead with extensive intracranial involvement.

Authors:  Ilka Charlotte Naumann; Susan R Cordes
Journal:  Ann Otol Rhinol Laryngol       Date:  2007-09       Impact factor: 1.547

5.  Basal cell carcinoma with intracranial invasion.

Authors:  Yekaterina Kleydman; Spiros Manolidis; Désirée Ratner
Journal:  J Am Acad Dermatol       Date:  2009-06       Impact factor: 11.527

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.